Nerve Disorder Guillain Barre Syndrome Officially Added As Side Effect For AstraZeneca COVID Vaccine
Nerve disorder Guillain Barre Syndrome has been officially added as a side effect for the AstraZeneca COVID vaccine branded as Covishield in India.
The Medicines and Healthcare products Regulatory Agency of UK has added a serious nerve disorder as a possible side effect to the AstraZeneca Covid-19 vaccine after a handful of cases were linked to the jab.
Guillain-Barre syndrome (GBS) itself is a rare nerve disorder that can cause paralysis, but recent data has shown the likelihood “of a possible association” to the vaccine “has strengthened,” according to the regulatory agency.
Of the millions who have received the AstraZeneca vaccine, there were 432 reports of GBS possibly stemming from the vaccine. There were 50 similar cases reported for the Pfizer vaccine.
In response, the agency has updated their information on AstraZeneca’s jab to include GBS as a rare, but possible, side effect.